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Abstract 
Proanthocyanidins (PCs), a component of grape seed extract (GSE), has recently being used 
for the treatment of wounds. However, poor absorption, poor stability and rapid elimination 
from the systemic circulation limit its acceptance. In addressing these problems, we herein 
report the development of PCs based nanoformulations (PCs/SOLU) for the first time based on 
1 % GSE and assessed its wound healing potential in-vivo on the wistar rats. GSE and 
PCs/SOLU nanodispersions 1 % were prepared by incorporating them into the ointment base 
via uniform mixing to form ointment which could be easily applied topically to wounds. The 
antibacterial activity of PCs/SOLU against gram positive and gram-negative bacteria strains 
proved that the cell membranes became more permeable with disrupted cell structure. While 
carrageenan and histamine induced rat paw edema analyses show there was no inflammatory 
signs in animals treated with 1 wt% of PCs/SOLU nanodispersion. Excision wound measuring 
about 3 cm in depth was created on the wistar rats. The ointment was applied topically on the 
wounded site and the wound contraction was measured daily. Grape seed extract (GSE) 
ointment, ointment base and povidone-iodine (Povi-Iod) ointment of about 1 % was used as 
the control, positive and negative standards. PCs/SOLU nanodispersion heals the wound by 
mobilising the fibroblasts in the wound site and inhibits the inflammatory response through 
decreased expression of monocyte. The macroscopical, immunological and histopathological 
assessments revealed that PCs/SOLU nanodispersion ointment usage improves the cell 
adhesion and proliferation 
 
Introduction 
Wound healing is formed by series of events such as proliferation and migration of cells in 
which the migration of cells occurs from blood components such as thrombocytes, 
macrophages and neutrophils. There are three important process required for successful wound al 
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healing such as fibroplasia, angiogenesis and re-epithelialisation. Fibroplasia is the stage in 
which the wound contraction occurs by the process of proliferation of fibroblasts[1,2]. 
Angiogenesis and re-epithelisation are the stages in which the wound contraction occurs in 
storing the matrix for the formation of new vein and epithelium. A delay in the development 
of these mechanisms leads to failure or prolong wound healing process[3– 8]. 
There are various topical and systemic agents used for the cure of wound and antimicrobial 
agents which are effective in preventing infections in surgical and traumatic wounds[9– 12]. 
However, these topical agents delays re-epithelialisation and might pose a risk of 
oversensitivity and resistance[13– 15]. For this reason, some alternative wound treatment 
methods have been investigated. Among these, the applications of plant based nanotechnology 
plays a significant role in the process of wound healing[16,17]. The plant based materials have 
proved at all times to be a powerful remedy for health care[18– 27]. Accordingly, the grape 
seed extract containing PCs have been investigated for wound treatment and in the management 
of many illnesses such as cancers, cardiovascular disease, gastric ulcers, obesity and skin 
inflammations. PCs also helps in promoting the formation of collagen and elastin and 
preservation of skin moisture. Furthermore, PCs induces vascular endothelial growth factor, 
reduces edema and encourages blood flow thereby accelerates wound healing[28– 33]. 
Khanna et al reported the outcome of grape seed extract (GSE) on in-vivo wound healing 
among nine male BalbC mice. They revealed that extract containing 2 % of resveratrol 
accelerated wound healing (P < 0.05). They also found that improved histological structure, 
deposition of connective tissue and increased proliferation stimulated the production of VEGF 
(vascular endothelial growth factor) at the wound edge[34]. In a work by Hemmati et al, they 
found that 2 % GSE enhanced the process of wound contraction and closure in rabbits, and 
reported a wound healing within 15 days[32]. In an another study, they have used a grape skin 
powder on full thickness skin lesions in mice and observed a wound healing occurred thirteen 
days after treatment begun [35]. The findings of their clinical study indicate that they have used 
5 % ointment of GSE on caesarean section (CS). They observed that it accelerates wound 
healing and reduce its closure time[31]. The findings of all these reported studies confirms that 
they have used about 2- 5 % of GSE without using any polymer. These works also reported 
poor stability and rapid elimination of GSE from systemic circulation. 
In addressing these problems, we have developed the PCs based nanoformulations for the first 
time based on 1 % GSE and assessed its wound healing potential. The outcomes of the current 
study indicate that 1 % of PCs/SOLU nanodispersion ointment of grape seed extract can 
accelerate excision wound healing and helps to eliminate the complications associated with the 
wounds such as inflammation and infections. In addition, the PCs/SOLU nanodispersion 
ointment can acts as an antioxidant, antibacterial and anti-inflammatory agent in-vivo and thus 
improved regeneration process in wounds. 
 
Materials 
 
Grape  seed  extract  (GSE)  used  in  this  study  was  purchased  from  JF  naturals,  China. 
Polyethylene glycol-polyvinyl acetate-polyvinyl caprolactam (Soluplus (SOLU)) were received 
from BASF Corporation, Mumbai. Hard paraffin, yellow soft paraffin, wool fat and cetosteryl 
alcohol were obtained from Sigma Aldrich, Mumbai. Hematoxylin, eosin, acetone, glacial acetic 
acid, xylene, NaCl, KCl, Na2HPO4 and K2HPO4 were procured from Merck, India. 
Formaldehyde was purchased from Fisher Scientific, India. The bacterial strains such as E.coli 
(ATCC25922) and S.aureus (ATCC 25923) were obtained from Saveetha Medical College, 
India. All the chemicals used were of analytical grade. 
Methods 
Freeze-drying 
The different ratios of PCs/SOLU (1:1 (FI), 1:3 (FII), 1:5 (FIII), 1:7 (FIV)) were dissolved in 
distilled water and the prepared solution was dispersed using magnetic stirrer at 125 rpm for 
30 min. Then, it was sonicated for 10 mins at 25 °C and the solution was frozen at −45 °CFinally, 
the frozen sample was subjected to lyophilisation at −84 °C with a pressure of 7×10−2 
mbar for 12 h using a freeze-dryer (Sub-Zero, USA) to obtain the dried solid. 
Loading Efficiency 
The percentage of PCs dispersed in SOLU was determined by membrane filtration method. 
PCs/SOLU of about 1 ml was filtered through the membrane with pore size of 0.22-μm, while 
non-dispersed PCs was retained in the membrane. 
Characterization 
The functional groups present in GSE, SOLU and GSE-SOLU dispersions were measured by 
Perkin Elmer FT-IR spectrometer in the frequency of 4000-500 cm-1 in attenuated total 
reflectance mode. The interactions between the PCs and SOLU were also investigated by FTIR 
measurements. The obtained spectra was baseline corrected by using Perkin Elmer 
Spectrum software. D8-Advance of Bruker XRD (Germany) was used to determine the 
crystallinity and the structure of the GSE, SOLU and PCs-SOLU dispersions with wavelength 
of 1.5405980 Å. The morphological analysis was carried out using JEOL Model-JEM2100 
transmission electron microscope (TEM). GSE, SOLU and GSE-SOLU dispersions were 
dissolved in water and analysed using JascoV-650 absorption spectrometer. Horiba nano 
zetasizer (UK) was used to measure the particle size distribution, polydispersity index (PDI) 
and zeta potential of GSE, SOLU and GSE-SOLU dispersions. 
In-vitro release assay 
The disso profile of PCs from SOLU was estimated using SIF (Simulated Intestinal Fluid). For 
the preparation of SIF, Wang et al’s procedure was adopted by mixing trypsin - 10 g/l, NaCl -9 g/l, 
pancreatin - 10 g/l and bile salts - 3 g/l. The pH of the fluid was adjusted to 6.8 [36]. Then the 
prepared fluid was incubated at 37 °C and continuously stirred using magnetic stirrer. 
During the initial 6 h period, 1 ml of the solution was withdrawn at 1 h interval and after 6 h 
aliquots were taken at every 3 h until 12 h period. After which aliquots were also taken at every 
8 h until 48 h. The withdrawn solutions was centrifuged at 14,000 rpm for 5 min and filtered 
using 0.45 μm Millipore. The PCs content was estimated by HPLC (Waters HPLC). GSE (10 
ml) was mixed in acetone/water/acetic acid (70/29.5/0.5 v/v/v) and this solution was filtered 
through 0.45 μm PVDF membrane. 10 μl of the solution was injected and the stationary phase used 
here was 5 μm, 250 × 4.6 mm silica column. Finally, the components were detected by fluorescence 
spectrometer. The obtained standard and the sample peaks were quantified and expressed in PCs 
mg/g of GSE. 
Antibacterial studies 
The qualitative and quantitative assay of the prepared nano dispersions was carried out using 
agar well diffusion method. The in-vitro antibacterial assay was performed based on the 
standards protocol given by National Committee for Clinical Laboratory Standards (NCCLS) 
protocol. The gram positive and gram-negative strains were used (E.coli, Bacillus and S. 
aureus). The samples analysed included the optimised PCs/SOLU nanodispersion (FIII), GSE 
and standard. The bacterial suspension (inoculum) was prepared by using Mac Farland (108 
CFU/ml) media. In the Mueller Hinton agar medium, the prepared inoculum was streaked over 
the surface and dried. The wells were created using sterile borer and the samples (Gentamycin, 
GSE, PCs-SOLU) dissolved in water was poured into the wells. Then the plates were kept for 
incubation at 37 °C for 24 h. The activity was measured by zone of inhibition developed around 
the wells. Finally, the images of all the plates were taken after developing zone of 
inhibitfluorescence spectrometer. The obtained standard and the sample peaks were quantified and 
expressed in PCs mg/g of GSE. 
Antibacterial studies 
The qualitative and quantitative assay of the prepared nano dispersions was carried out using 
agar well diffusion method. The in-vitro antibacterial assay was performed based on the 
standards protocol given by National Committee for Clinical Laboratory Standards (NCCLS) 
protocol. The gram positive and gram-negative strains were used (E.coli, Bacillus and S. 
aureus). The samples analysed included the optimised PCs/SOLU nanodispersion (FIII), GSE 
and standard. The bacterial suspension (inoculum) was prepared by using Mac Farland (108 
CFU/ml) media. In the Mueller Hinton agar medium, the prepared inoculum was streaked over 
the surface and dried. The wells were created using sterile borer and the samples (Gentamycin, 
GSE, PCs-SOLU) dissolved in water was poured into the wells. Then the plates were kept for 
incubation at 37 °C for 24 h. The activity was measured by zone of inhibition developed around 
the wells. Finally, the images of all the plates were taken after developing zone of inhibition 
and were used to support the antibacterial activity. 
Susceptibility tests by SEM analysis 
The bacterial strains were individually cultured in LB broth and incubated at 37° C for 24 h. 
Then the prepared broth was diluted again with fresh LB broth to reach the optimum density. 
The glutaraldehyde was dissolved in PBS with pH 7.4 to make 2.5 % v/v. GSE, gentamycin 
and GSE-SOLU nanodispersions were taken (1 mg) and kept in LB broth. Bacterial strains 
were streaked on to the plates and incubated for 24 h at 37 °C. The glass slides coated with 
poly lysine were taken and few drops of the samples were added. Then poly lysine coated glass 
slides were fixed with glutaraldehyde solution and washed with PBS three times. This was 
followed by storage at 4 °C and dehydration using ethanol (70 %, 96 % and 100 % v/v). Again 
the glass slides were dried by critical point dryer (EMS 850) and gold coated for analysing in 
SEM. 
Anti-Susceptibility tests by SEM analysis 
The bacterial strains were individually cultured in LB broth and incubated at 37° C for 24 h. 
Then the prepared broth was diluted again with fresh LB broth to reach the optimum density. 
The glutaraldehyde was dissolved in PBS with pH 7.4 to make 2.5 % v/v. GSE, gentamycin 
and GSE-SOLU nanodispersions were taken (1 mg) and kept in LB broth. Bacterial strains 
were streaked on to the plates and incubated for 24 h at 37 °C. The glass slides coated with 
poly lysine were taken and few drops of the samples were added. Then poly lysine coated glass 
slides were fixed with glutaraldehyde solution and washed with PBS three times. This was 
followed by storage at 4 °C and dehydration using ethanol (70 %, 96 % and 100 % v/v). Again 
the glass slides were dried by critical point dryer (EMS 850) and gold coated for analysing in 
SEM. 
Anti-inflammatory activity 
Membrane stabilization test 
Human blood of about 10 ml was collected and kept in the centrifuge tubes and the tubes 
containing blood were centrifuged for 10 mins. After centrifugation, the samples were washed with 
saline three times and the volume was measured. Then to the measured volume, saline 
was added to get a reconstituted suspension of about 10 % v/v. 
Heat-induced haemolytic assay 
The test samples were prepared using 1 ml of reconstituted red blood cells (RBCs) suspension 
(10 %) and 1 ml of PCs/SOLU nanodispersion solution. The standards and control were 
prepared using diclofenac sodium and saline solution (10 % v/v). The samples, standard and 
the control containing centrifuge tubes were incubated for 30 mins at 56º C. The tubes were 
cooled and centrifuged for 5 min at a speed of 2500 rpm. All the samples were made in 
triplicates and the corresponding supernatants was collected. The absorbance was measured at 
560 nm. The percentage membrane stabilizing activity was evaluated using the following 
formula; 
Haemolysis Inhibition (%) = AbsStd − AbsTest AbsStd × 100 
Carrageenan and histamine induced rat paw edema 
The method of Winter et al. was utilised with a slight modification[37,38]. Wistar rats was used 
for this study and were divided into four groups. Each group consist of six animals. For all the 
animals in all the groups, acute inflammation was induced using phlogistic agents such as 
carrageenan and histamine (1 % of 0.1 ml) by administration of subcutaneous injection in the 
hind paw (right side). The paw volume was noted before and after injection to calculate the 
increase or decrease in the inflammation. Then, the diclofenac sodium ointment was 
administered topically on the hind paw of standard group animals. For the positive and negative 
control group animals, GSE and the ointment base was applied topically. And for the test group 
animals, PCs/SOLU nanodispersion ointment was administered on the hind paw topically. 
After application of ointment, the paw volume was measured continuously every hour for 6 h 
using plethysmometer. 
Topical semisolid preparation 
The ointment base (5 g) was prepared by mixing wool fat –  0.250 g, yellow soft paraffin –  4 g, 
hard paraffin –  0.5 g and cetosteryl alcohol –  0.250 g in china dish. Then, the china dish was 
placed on the water bath which is maintained at a temperature of 50 oC till the contents gets 
liquefied. The quantity required for the preparation of PCs/SOLU nanodispersion ointment is 
1 % w/w and this was mixed with the melted ointment base and stirred continuously till a 
homogeneous dispersion was obtained. The same method was followed to prepare GSE 
ointment. 
Excision wound model 
Twenty four adult Wistar rats were divided into four groups of six animals each. The animals 
were given ketamine intraperitoneal injection as an anaesthetic (100 mg/kg). The dorsal 
thoracic area which is 1 cm away from the vertebral column was cleaned and shaved. After 
shaving the hair follicles, the area in which the wound was to be created was made circular 
using stainless steel stencil with methylene blue. The excision wounds was created using 
toothed forceps, surgical blade and pointed scissors of about 3 cm in depth. The cotton swab 
was soaked in saline to clean the wound area and the created wound was left open after attaining 
haemostasis. The created wound of all the animals was with full thickness which was beneath 
the adipose tissue. The wound created day was noted and it was considered as day zero and the 
wound was cleaned daily using methylated spirit before ointment application. Appropriate 
quantity of ointment base, GSE, Povi/Iod, and PCs/SOLU nanodispersion ointment was 
applied daily to each individual groups till the complete healing was observed. Area of wound 
was measured by millimetre scale graph paper and the wound contraction percentage was 
measured based on the initial wound area. The time taken for complete epithelialisation (i.e., 
time required for the dead tissue to fall off without any residues) was also measured.  
Histopathological analysis of open wound 
The rats were sacrificed on the 12th day and the skin was excised from the wound area. The 
excised skin were kept in isotonic saline solution and in deep freezer at −20 °C for storage. Using 
Leica CM1950 cryostat cutter, the excised skin were cut into 5 μm thin sections. Eight skin sections 
of each samples were prepared. Using Leica tissue freezing medium (Germany), the sectioned skin 
was fixed in the glass slides. Each sample containing eight skin sections were prepared and stained 
by Leica AutostainerXL using hematoxylin and eosin. After staining  procedure, the sectioned 
samples were visualised using Leica compound microscope (DF2500) which is fitted with camera 
to capture illustrative images. 
Statistical analysis 
The statistical evaluation was performed by using ANOVA and Turkey Krammer Multiple 
Comparison Test. The p<0.05 value was observed to be statistically significant. 
 
Results and Discussion 
PCs loading 
PCs (PCs –  1%) -SOLU were prepared with different theoretical SOLU loading, i.e., 1 % (FI), 
3 % (FII), 5 % (FIII) and 7 % (FIV) of polymer. The particle size of the FIII formulation was 
found to be the smallest particle size (69.90 ± 2.12 nm) with PDI of 0.154 ± 0.023 (Fig 1 (a)). 
The polymer SOLU loading of 5 % (FIII) resulted in stable formulation with highest loading 
efficiency (95.36 % ± 2.06 %) and negative zeta potential (-82.1 ± 1.07) (Fig 1 (b)). Therefore, 
the formulation (FIII) was selected for further physicochemical characterization. 
 
 
Fig 1 (a) Particle size, (b) Zeta potential of FIII formulation and (c) Chemical structure of 
proanthocyanidins (PCs). 
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Optical and structural analyses 
The PCs/SOLU nanodispersion formulations were characterized by XRD analysis, UV-Vis 
analysis, FT-IR analysis, particle size, loading efficiency and TEM analysis (Fig 2). PCs 
exhibited a peak around 270 to 280 nm (Fig 2 (a)) which represents the π-π * transition caused  by 
the presence of double bond (unsaturation). The peak is completely absent in SOLU due to the 
absence of unsaturation. In addition, the intensity of π-π * peak of PCs decreases with the addition 
of SOLU. This is due to the π-π interactions coming from keto part of SOLU and double bond from 
the PCs. In the FT-IR spectra, the position of the carbonyl peak in the FIII formulation shifted to 
1738 cm−1 and this shifting leads to polar-polar interactions. The FIII 
formulation, also shows a peak broadening from 3619 cm−1 to 3265 cm−1 which indicates the 
formation of intermolecular hydrogen bonding between PCs and SOLU (Fig 2 (b)). The 
diffraction pattern of the SOLU and PCs showed broad peaks at 20 and 22 indicating their 
amorphous nature. The addition of SOLU to the PCs completely eliminates the broad peak 
indicating hydrogen bonding and π-π interactions. The FIII formulation PCs/SOLU dispersion 
showed no characteristic peak which indicates completely amorphous nature (Fig 2 (c)). The 
TEM images showed that SOLU (Fig 2 (d)) has a flat thin sheet-like morphology while PCs 
(Fig 2 (e)) appears as spherical shaped structure. It is clearly evident from the FIII formulation 
micrograph Fig 2 (f) that the spherically shaped particles of PCs are embedded on the surface 
of the polymer SOLU. 
 
 
 
 
  
Fig 2 (a) UV-visible spectra, (b) FTIR spectra and (c) XRD pattern of SOLU, PCs and FIII 
formulation and TEM image of (d) Soluplus (SOLU) (0.5 μm), (e) Grape seed extract (PCs) 
(0.5 μm) and (f) PCs/SOLU (100 nm) used for the study. 
In-vitro release 
The pure GSE in SIF showed about 97.33 % release in 2 h and the PCs revealed a controlled 
release behaviour from SOLU (Fig 3). They exhibited a lower burst effect with 20.00 % in 2 h 
and at 48 h about 68.05 % was released in controlled manner. The reason for the controlled 
release profile of PCs was due to the interaction or affinity between the polymer and SOLU. 
The PCs shows about 45-50 % of GSE released in 6 h time period. Similar result had been 
reported by Lu et al’s work for the procyanidins release in tea after 6 h[39]. 
 
Antibacterial study 
The antimicrobial activity of standard, GSE and GSE-SOLU solid dispersion was tested using 
the agar well diffusion method (Fig 4 A). The zone of inhibition as seen in Fig 4 B showed the 
range of 3-6 mm for standard, 5-8.5 mm for GSE and 9-13 mm for GSE-SOLU solid dispersion 
(FIII). The result of the present investigation highlights the greater antibacterial potential of the 
solid dispersion than for the plain GSE and the standard drug. The main mechanism for the 
bactericidal activity of PCs/SOLU nanodispersion is shown in Fig 5. When the nanodispersion, 
FIII (1:5) was placed in the medium, the polymer matrix become swollen. When PCs/SOLU 
encountered the positively charged ions in the solution, ion exchange took place, which 
wasnegative organism which is anaerobic, rod shaped bacteria and it contains fimbria, outer cell 
membrane with lipopolysaccharides, peptidoglycan layer and inner cytoplasm[40]. By means 
of electrostatic interactions, the PCs which are positively charged gets attracted to the bacterial 
cell membrane which is negatively charged. These interactions leads to oxidative damage 
which makes the cell membrane more permeable. When more PCs enter the cells it damages 
the genetic material DNA by releasing ROS (reactive oxygen species). The next part explains 
the susceptibility of bacteria by SEM analysis which confirms the proposed mechanism 
showing antibacterial activity. 
Anti-inflammatory activity 
Table 1 shows the anti-inflammatory activity of PCs/SOLU nanodispersion and standard 
diclofenac sodium. PCs/SOLU nanodispersion displayed 41.83 % activity, which is almost 
similar to the percentage heat-induced by haemolysis of diclofenac sodium. Therefore, the 
antiinflammatory activity of PCs/SOLU and diclofenac shows no significant difference. The main 
mechanism of the anti-inflammatory action is the inhibition of the metabolism of arachidonic 
acid by preventing the action of COX, lipoxygenase, phospholipase and A2. By inhibiting the 
action of inflammatory enzymes, PCs/SOLU provides a defensive effect against the wounds 
inflammatory reactions[45]. As a result, the PCs/SOLU was observed to be an effective 
antiinflammatory 
agent. 
 
Membrane stabilizing activity 
Membrane stabilising activity showed that PCs/SOLU inhibit the lysis of erythrocytes. In 
general, leucocytes migrates to the inflammation site in response to the stimulus which plays a 
vital role during inflammatory disorders[46,47]. The PCs/SOLU nanodispersion ointment 
lowers the occurrence of radicals (super oxide) by preventing the leucocytes migration at the 
inflammation site. The PCs/SOLU nanodispersion ointment and the diclofenac ointment 
treated groups shows decreased leucocyte counts. In addition, PCs/SOLU treated animals show 
higher percentage of inhibition of heat induced by haemolysis of erythrocytes when compared 
to the diclofenac sodium. They displayed the concentration dependent inhibition of haemolytic 
activity. Furthermore, PCs/SOLU prevents the rupture of the erythrocytes membrane by 
releasing the hydrolytic enzymes from lysosome to prevent the damage of the tissues. These 
membrane stabilization results (Table 1) proves that it is a significant assay for antiinflammatory 
activity. 
 The PCs/SOLU ointment and diclofenac sodium ointment were administered to control and 
treatment groups. Both the ointments inhibited the hind paw edema, which was examined at 
every hour of the experiment. The results show significant reduction in the histamine induced 
paw edema. In the first hour after the administration of diclofenac sodium ointment, the 
maximal paw thickness was observed. Whereas in the case of PCs/SOLU ointment application, 
a statistically significant inhibition of the edema in the histamine induced assay occurred. This 
becomes more significant after 2 h and 3 h (Fig 9 (a)). The edema and inflammation were 
caused by 5-HT and histamine which is due to the release of prostaglandins into the 
inflammation site. This occurred due to the leucocytes migration to the inflamed site. 
PCs/SOLU inhibited the release of inflammatory mediators such as 5-HT and histamine and 
thereby inhibiting the edema formation during the first hour. In the next 2 h, they prevented the 
release of histamine and serotonin, potent vasodilator substances that increases the vascular The 
PCs/SOLU ointment and diclofenac sodium ointment were administered to control and 
treatment groups. Both the ointments inhibited the hind paw edema, which was examined at 
every hour of the experiment. The results show significant reduction in the histamine induced 
paw edema. In the first hour after the administration of diclofenac sodium ointment, the 
maximal paw thickness was observed. Whereas in the case of PCs/SOLU ointment application, 
a statistically significant inhibition of the edema in the histamine induced assay occurred. This 
becomes more significant after 2 h and 3 h (Fig 9 (a)). The edema and inflammation were 
caused by 5-HT and histamine which is due to the release of prostaglandins into the 
inflammation site. This occurred due to the leucocytes migration to the inflamed site. 
PCs/SOLU inhibited the release of inflammatory mediators such as 5-HT and histamine and 
thereby inhibiting the edema formation during the first hour. In the next 2 h, they prevented the 
release of histamine and serotonin, potent vasodilator substances that increases the vascular 
permeability (Fig 9 (b)). In the late phase, PCs/SOLU inhibited the synthesis of prostaglandins 
which is regarded as the most sensitive phase of anti-inflammatory action. 
 
Fig 9 (a) The effects of vehicle (control), diclofenac sodium (standard) and PCs/SOLU in 
histamine induced rat paw edema and (b) carrageenan induced rat paw edema. 
 
Conclusion 
In this study, PCs/SOLU nanodispersion were successfully prepared and characterized. The 
prepared PCs/SOLU nanodispersion has polar-polar interactions and indicates the 
intermolecular hydrogen bonding formation between PCs and SOLU. SEM and TEM analysis 
confirmed the presence of spherical shaped PCs which were homogeneously distributed in the 
polymer matrix (SOLU). The antibacterial activity of PCs/SOLU against E.coli, S.aureus and 
Bacillus proved that the cell membranes became more permeable with disrupted cell structure 
when treated with nanodispersion. It was evident from the susceptibility tests that the bacterial 
morphology changed to very small thin structures and blebs were found as aggregates on the 
cell surface. Carrageenan and histamine induced rat paw edema analyses show there was no 
inflammatory signs in animals treated with 1 wt% of PCs/SOLU nanodispersion. Application 
of PCs/SOLU nanodispersion ointment in wound healing revealed that it improves process of 
wound healing without scar formation when compared to the control, positive and negative 
standards. The histopathological assay of PCs/SOLU treated animals showed complete 
reepithelialisation, 
migration of cells, proliferation of cells and fibroblast attachment. Thus, the 
prepared PCs/SOLU nanodispersion ointment can be used as an effective wound healing 
component. 
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